Applied Therapeutics Inc (APLT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-04 | S Sale |
Chief Medical Officer Officer |
10,366
-1.2%
0.44USD 4,561 |
10,366 -1.2% | 0.44 | USD 4,561 | |
| 2025-03-06 | 2025-03-04 | S Sale |
See Remarks Officer |
447
-0.2%
0.44USD 197 |
447 -0.2% | 0.44 | USD 197 | |
| 2025-03-06 | 2025-03-04 | S Sale |
See Remarks Executive Director |
14,502
-3.6%
0.44USD 6,381 |
14,502 -3.6% | 0.44 | USD 6,381 | |
| 2025-02-07 | 2025-02-06 | S Sale |
Chief Medical Officer Officer |
86,078
-8.7%
0.61USD 52,508 |
86,078 -8.7% | 0.61 | USD 52,508 | |
| 2025-02-07 | 2025-02-06 | S Sale |
See Remarks Officer |
28,117
-9.4%
0.61USD 17,151 |
28,117 -9.4% | 0.61 | USD 17,151 | |
| 2025-02-07 | 2025-02-06 | S Sale |
See Remarks Executive Director |
22,950
-5.4%
0.61USD 14,000 |
22,950 -5.4% | 0.61 | USD 14,000 | |
| 2024-08-23 | 2024-08-22 | S Sale |
Chief Medical Officer Officer |
22,681
-2.2%
5.83USD 132,230 |
22,681 -2.2% | 5.83 | USD 132,230 | |
| 2024-08-23 | 2024-08-22 | S Sale |
Chief Financial Officer Executive Director |
13,530
-4.6%
5.83USD 78,880 |
13,530 -4.6% | 5.83 | USD 78,880 | |
| 2024-08-14 | 2024-08-14 | S Sale |
President and CEO Executive Director |
119,591
-2.5%
5.93USD 709,175 |
119,591 -2.5% | 5.93 | USD 709,175 | |
| 2024-08-14 | 2024-08-13 | S Sale |
President and CEO Executive Director |
357,423
-6.9%
6.18USD 2,208,874 |
357,423 -6.9% | 6.18 | USD 2,208,874 | |
| 2024-08-14 | 2024-08-12 | S Sale |
President and CEO Executive Director |
300,000
-5.5%
5.98USD 1,794,000 |
300,000 -5.5% | 5.98 | USD 1,794,000 | |
| 2024-06-10 | 2024-06-06 | S Sale |
President and CEO Executive Director Large shareholder |
61,795
-1.6%
4.32USD 266,954 |
61,795 -1.6% | 4.32 | USD 266,954 | |
| 2024-06-10 | 2024-06-06 | S Sale |
Chief Financial Officer Executive Director |
16,980
-5.5%
4.32USD 73,354 |
16,980 -5.5% | 4.32 | USD 73,354 | |
| 2024-06-10 | 2024-06-06 | S Sale |
Chief Medical Officer Officer |
22,003
-2.1%
4.32USD 95,053 |
22,003 -2.1% | 4.32 | USD 95,053 | |
| 2024-06-06 | 2024-06-05 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150,000
-2.5%
4.24USD 636,000 |
150,000 -2.5% | 4.24 | USD 636,000 | |
| 2024-06-06 | 2024-06-04 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150,000
-2.4%
4.21USD 631,500 |
150,000 -2.4% | 4.21 | USD 631,500 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Commercial Officer Officer |
48,871
-6.3%
5.39USD 263,415 |
48,871 -6.3% | 5.39 | USD 263,415 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Medical Officer Officer |
110,804
-9.7%
5.39USD 597,234 |
110,804 -9.7% | 5.39 | USD 597,234 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Financial Officer Executive Director |
28,727
-8.5%
5.39USD 154,839 |
28,727 -8.5% | 5.39 | USD 154,839 | |
| 2024-03-18 | 2024-03-14 | S Sale |
President and CEO Executive Director Large shareholder |
318,573
-7.7%
5.39USD 1,717,108 |
318,573 -7.7% | 5.39 | USD 1,717,108 |